Identification of a competing endogenous RNA network associated with prognosis of pancreatic adenocarcinoma
Background Emerging evidence suggests that competing endogenous RNAs plays a crucial role in the development and progress of pancreatic adenocarcinoma (PAAD). The objective was to identify a new lncRNA-miRNA-mRNA network as prognostic markers, and develop and validate a multi-mRNAs-based classifier...
Saved in:
Published in | Cancer cell international Vol. 20; no. 1; pp. 231 - 14 |
---|---|
Main Authors | , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
London
BioMed Central
11.06.2020
BMC |
Subjects | |
Online Access | Get full text |
ISSN | 1475-2867 1475-2867 |
DOI | 10.1186/s12935-020-01243-6 |
Cover
Abstract | Background
Emerging evidence suggests that competing endogenous RNAs plays a crucial role in the development and progress of pancreatic adenocarcinoma (PAAD). The objective was to identify a new lncRNA-miRNA-mRNA network as prognostic markers, and develop and validate a multi-mRNAs-based classifier for predicting overall survival (OS) in PAAD.
Methods
Data on pancreatic RNA expression and clinical information of 445 PAAD patients and 328 normal subjects were downloaded from The Cancer Genome Atlas (TCGA), International Cancer Genome Consortium (ICGC) and Genotype-Tissue Expression (GTEx). The weighted correlation network analysis (WGCNA) was used to analyze long non-coding RNA (lncRNA) and mRNA, clustering genes with similar expression patterns. MiRcode was used to predict the sponge microRNAs (miRNAs) corresponding to lncRNAs. The downstream targeted mRNAs of miRNAs were identified by starBase, miRDB, miRTarBase and Targetscan. A multi-mRNAs-based classifier was develop using least absolute shrinkage and selection operator method (LASSO) COX regression model, which was tested in an independent validation cohort.
Results
A lncRNA-miRNA-mRNA co-expression network which consisted of 60 lncRNAs, 3 miRNAs and 3 mRNAs associated with the prognosis of patients with PAAD was established. In addition, we constructed a 14-mRNAs-based classifier based on a training cohort composed of 178 PAAD patients, of which the area under receiver operating characteristic (AUC) in predicting 1-year, 3-year, and 5-year OS was 0.719, 0.806 and 0.794, respectively. The classifier also shown good prediction function in independent verification cohorts, with the AUC of 0.604, 0.639 and 0.607, respectively.
Conclusions
A novel competitive endogenous RNA (ceRNA) network associated with progression of PAAD could be used as a reference for future molecular biology research. |
---|---|
AbstractList | Background Emerging evidence suggests that competing endogenous RNAs plays a crucial role in the development and progress of pancreatic adenocarcinoma (PAAD). The objective was to identify a new lncRNA-miRNA-mRNA network as prognostic markers, and develop and validate a multi-mRNAs-based classifier for predicting overall survival (OS) in PAAD. Methods Data on pancreatic RNA expression and clinical information of 445 PAAD patients and 328 normal subjects were downloaded from The Cancer Genome Atlas (TCGA), International Cancer Genome Consortium (ICGC) and Genotype-Tissue Expression (GTEx). The weighted correlation network analysis (WGCNA) was used to analyze long non-coding RNA (lncRNA) and mRNA, clustering genes with similar expression patterns. MiRcode was used to predict the sponge microRNAs (miRNAs) corresponding to lncRNAs. The downstream targeted mRNAs of miRNAs were identified by starBase, miRDB, miRTarBase and Targetscan. A multi-mRNAs-based classifier was develop using least absolute shrinkage and selection operator method (LASSO) COX regression model, which was tested in an independent validation cohort. Results A lncRNA-miRNA-mRNA co-expression network which consisted of 60 lncRNAs, 3 miRNAs and 3 mRNAs associated with the prognosis of patients with PAAD was established. In addition, we constructed a 14-mRNAs-based classifier based on a training cohort composed of 178 PAAD patients, of which the area under receiver operating characteristic (AUC) in predicting 1-year, 3-year, and 5-year OS was 0.719, 0.806 and 0.794, respectively. The classifier also shown good prediction function in independent verification cohorts, with the AUC of 0.604, 0.639 and 0.607, respectively. Conclusions A novel competitive endogenous RNA (ceRNA) network associated with progression of PAAD could be used as a reference for future molecular biology research. Emerging evidence suggests that competing endogenous RNAs plays a crucial role in the development and progress of pancreatic adenocarcinoma (PAAD). The objective was to identify a new lncRNA-miRNA-mRNA network as prognostic markers, and develop and validate a multi-mRNAs-based classifier for predicting overall survival (OS) in PAAD. Data on pancreatic RNA expression and clinical information of 445 PAAD patients and 328 normal subjects were downloaded from The Cancer Genome Atlas (TCGA), International Cancer Genome Consortium (ICGC) and Genotype-Tissue Expression (GTEx). The weighted correlation network analysis (WGCNA) was used to analyze long non-coding RNA (lncRNA) and mRNA, clustering genes with similar expression patterns. MiRcode was used to predict the sponge microRNAs (miRNAs) corresponding to lncRNAs. The downstream targeted mRNAs of miRNAs were identified by starBase, miRDB, miRTarBase and Targetscan. A multi-mRNAs-based classifier was develop using least absolute shrinkage and selection operator method (LASSO) COX regression model, which was tested in an independent validation cohort. A lncRNA-miRNA-mRNA co-expression network which consisted of 60 lncRNAs, 3 miRNAs and 3 mRNAs associated with the prognosis of patients with PAAD was established. In addition, we constructed a 14-mRNAs-based classifier based on a training cohort composed of 178 PAAD patients, of which the area under receiver operating characteristic (AUC) in predicting 1-year, 3-year, and 5-year OS was 0.719, 0.806 and 0.794, respectively. The classifier also shown good prediction function in independent verification cohorts, with the AUC of 0.604, 0.639 and 0.607, respectively. A novel competitive endogenous RNA (ceRNA) network associated with progression of PAAD could be used as a reference for future molecular biology research. Background Emerging evidence suggests that competing endogenous RNAs plays a crucial role in the development and progress of pancreatic adenocarcinoma (PAAD). The objective was to identify a new lncRNA-miRNA-mRNA network as prognostic markers, and develop and validate a multi-mRNAs-based classifier for predicting overall survival (OS) in PAAD. Methods Data on pancreatic RNA expression and clinical information of 445 PAAD patients and 328 normal subjects were downloaded from The Cancer Genome Atlas (TCGA), International Cancer Genome Consortium (ICGC) and Genotype-Tissue Expression (GTEx). The weighted correlation network analysis (WGCNA) was used to analyze long non-coding RNA (lncRNA) and mRNA, clustering genes with similar expression patterns. MiRcode was used to predict the sponge microRNAs (miRNAs) corresponding to lncRNAs. The downstream targeted mRNAs of miRNAs were identified by starBase, miRDB, miRTarBase and Targetscan. A multi-mRNAs-based classifier was develop using least absolute shrinkage and selection operator method (LASSO) COX regression model, which was tested in an independent validation cohort. Results A lncRNA-miRNA-mRNA co-expression network which consisted of 60 lncRNAs, 3 miRNAs and 3 mRNAs associated with the prognosis of patients with PAAD was established. In addition, we constructed a 14-mRNAs-based classifier based on a training cohort composed of 178 PAAD patients, of which the area under receiver operating characteristic (AUC) in predicting 1-year, 3-year, and 5-year OS was 0.719, 0.806 and 0.794, respectively. The classifier also shown good prediction function in independent verification cohorts, with the AUC of 0.604, 0.639 and 0.607, respectively. Conclusions A novel competitive endogenous RNA (ceRNA) network associated with progression of PAAD could be used as a reference for future molecular biology research. Emerging evidence suggests that competing endogenous RNAs plays a crucial role in the development and progress of pancreatic adenocarcinoma (PAAD). The objective was to identify a new lncRNA-miRNA-mRNA network as prognostic markers, and develop and validate a multi-mRNAs-based classifier for predicting overall survival (OS) in PAAD.BACKGROUNDEmerging evidence suggests that competing endogenous RNAs plays a crucial role in the development and progress of pancreatic adenocarcinoma (PAAD). The objective was to identify a new lncRNA-miRNA-mRNA network as prognostic markers, and develop and validate a multi-mRNAs-based classifier for predicting overall survival (OS) in PAAD.Data on pancreatic RNA expression and clinical information of 445 PAAD patients and 328 normal subjects were downloaded from The Cancer Genome Atlas (TCGA), International Cancer Genome Consortium (ICGC) and Genotype-Tissue Expression (GTEx). The weighted correlation network analysis (WGCNA) was used to analyze long non-coding RNA (lncRNA) and mRNA, clustering genes with similar expression patterns. MiRcode was used to predict the sponge microRNAs (miRNAs) corresponding to lncRNAs. The downstream targeted mRNAs of miRNAs were identified by starBase, miRDB, miRTarBase and Targetscan. A multi-mRNAs-based classifier was develop using least absolute shrinkage and selection operator method (LASSO) COX regression model, which was tested in an independent validation cohort.METHODSData on pancreatic RNA expression and clinical information of 445 PAAD patients and 328 normal subjects were downloaded from The Cancer Genome Atlas (TCGA), International Cancer Genome Consortium (ICGC) and Genotype-Tissue Expression (GTEx). The weighted correlation network analysis (WGCNA) was used to analyze long non-coding RNA (lncRNA) and mRNA, clustering genes with similar expression patterns. MiRcode was used to predict the sponge microRNAs (miRNAs) corresponding to lncRNAs. The downstream targeted mRNAs of miRNAs were identified by starBase, miRDB, miRTarBase and Targetscan. A multi-mRNAs-based classifier was develop using least absolute shrinkage and selection operator method (LASSO) COX regression model, which was tested in an independent validation cohort.A lncRNA-miRNA-mRNA co-expression network which consisted of 60 lncRNAs, 3 miRNAs and 3 mRNAs associated with the prognosis of patients with PAAD was established. In addition, we constructed a 14-mRNAs-based classifier based on a training cohort composed of 178 PAAD patients, of which the area under receiver operating characteristic (AUC) in predicting 1-year, 3-year, and 5-year OS was 0.719, 0.806 and 0.794, respectively. The classifier also shown good prediction function in independent verification cohorts, with the AUC of 0.604, 0.639 and 0.607, respectively.RESULTSA lncRNA-miRNA-mRNA co-expression network which consisted of 60 lncRNAs, 3 miRNAs and 3 mRNAs associated with the prognosis of patients with PAAD was established. In addition, we constructed a 14-mRNAs-based classifier based on a training cohort composed of 178 PAAD patients, of which the area under receiver operating characteristic (AUC) in predicting 1-year, 3-year, and 5-year OS was 0.719, 0.806 and 0.794, respectively. The classifier also shown good prediction function in independent verification cohorts, with the AUC of 0.604, 0.639 and 0.607, respectively.A novel competitive endogenous RNA (ceRNA) network associated with progression of PAAD could be used as a reference for future molecular biology research.CONCLUSIONSA novel competitive endogenous RNA (ceRNA) network associated with progression of PAAD could be used as a reference for future molecular biology research. Abstract Background Emerging evidence suggests that competing endogenous RNAs plays a crucial role in the development and progress of pancreatic adenocarcinoma (PAAD). The objective was to identify a new lncRNA-miRNA-mRNA network as prognostic markers, and develop and validate a multi-mRNAs-based classifier for predicting overall survival (OS) in PAAD. Methods Data on pancreatic RNA expression and clinical information of 445 PAAD patients and 328 normal subjects were downloaded from The Cancer Genome Atlas (TCGA), International Cancer Genome Consortium (ICGC) and Genotype-Tissue Expression (GTEx). The weighted correlation network analysis (WGCNA) was used to analyze long non-coding RNA (lncRNA) and mRNA, clustering genes with similar expression patterns. MiRcode was used to predict the sponge microRNAs (miRNAs) corresponding to lncRNAs. The downstream targeted mRNAs of miRNAs were identified by starBase, miRDB, miRTarBase and Targetscan. A multi-mRNAs-based classifier was develop using least absolute shrinkage and selection operator method (LASSO) COX regression model, which was tested in an independent validation cohort. Results A lncRNA-miRNA-mRNA co-expression network which consisted of 60 lncRNAs, 3 miRNAs and 3 mRNAs associated with the prognosis of patients with PAAD was established. In addition, we constructed a 14-mRNAs-based classifier based on a training cohort composed of 178 PAAD patients, of which the area under receiver operating characteristic (AUC) in predicting 1-year, 3-year, and 5-year OS was 0.719, 0.806 and 0.794, respectively. The classifier also shown good prediction function in independent verification cohorts, with the AUC of 0.604, 0.639 and 0.607, respectively. Conclusions A novel competitive endogenous RNA (ceRNA) network associated with progression of PAAD could be used as a reference for future molecular biology research. |
ArticleNumber | 231 |
Author | Shan, Yunfeng Lin, Zhuo Weng, Wanqing Zhang, Zhongjing Wu, Boda Shi, Keqing Xu, Xiangxiang Huang, Weiguo Ye, Tingbo |
Author_xml | – sequence: 1 givenname: Wanqing surname: Weng fullname: Weng, Wanqing organization: Zhejiang Provincial Key Laboratory, The First Affiliated Hospital of Wenzhou Medical University, Precision Medicine Center Laboratory, The First Affiliated Hospital of Wenzhou Medical University – sequence: 2 givenname: Zhongjing surname: Zhang fullname: Zhang, Zhongjing organization: Zhejiang Provincial Key Laboratory, The First Affiliated Hospital of Wenzhou Medical University – sequence: 3 givenname: Weiguo surname: Huang fullname: Huang, Weiguo organization: Zhejiang Provincial Key Laboratory, The First Affiliated Hospital of Wenzhou Medical University – sequence: 4 givenname: Xiangxiang surname: Xu fullname: Xu, Xiangxiang organization: Zhejiang Provincial Key Laboratory, The First Affiliated Hospital of Wenzhou Medical University – sequence: 5 givenname: Boda surname: Wu fullname: Wu, Boda organization: Zhejiang Provincial Key Laboratory, The First Affiliated Hospital of Wenzhou Medical University, Precision Medicine Center Laboratory, The First Affiliated Hospital of Wenzhou Medical University – sequence: 6 givenname: Tingbo surname: Ye fullname: Ye, Tingbo organization: Zhejiang Provincial Key Laboratory, The First Affiliated Hospital of Wenzhou Medical University – sequence: 7 givenname: Yunfeng surname: Shan fullname: Shan, Yunfeng email: shanyunfeng@wmu.edu.cn organization: Department of Hepatobiliary Surgery, The First Affiliated Hospital of Wenzhou Medical University – sequence: 8 givenname: Keqing orcidid: 0000-0002-5070-3834 surname: Shi fullname: Shi, Keqing email: skochilly@wmu.edu.cn organization: Zhejiang Provincial Key Laboratory, The First Affiliated Hospital of Wenzhou Medical University, Precision Medicine Center Laboratory, The First Affiliated Hospital of Wenzhou Medical University – sequence: 9 givenname: Zhuo surname: Lin fullname: Lin, Zhuo email: biolinz@163.com organization: Department of Liver Diseases, The First Affiliated Hospital of Wenzhou Medical University |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/32536819$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kktv1DAUhSNURB_wB1igSGzYBPyKHxukqqJlpAokBGvrxrFTTzN2sDOt-Pd4Ji20XXRjW_Y5n47vvcfVQYjBVtVbjD5iLPmnjImibYMIahAmjDb8RXWEmWgbIrk4eHA-rI5zXiOEheToVXVISUu5xOqoul71NszeeQOzj6GOrobaxM1kZx-G2oY-DjbEba5_fDutg51vY7quIedoPMy2r2_9fFVPKQ4hZp93_gmCSbbgTA0FHg0k40PcwOvqpYMx2zd3-0n16_zLz7OvzeX3i9XZ6WVjOMNz01FwVAguBEWsFZJK5Szj0pUVG8V7Bc50RgphZd-hVmAHhBgJPRVUtC09qVYLt4-w1lPyG0h_dASv9xcxDRpSiTda7VBPQSnbS0oZAO-EZQyUdQwZQjpeWJ8X1rTtNrY3pVgJxkfQxy_BX-kh3mhBZKk1LYAPd4AUf29tnvXGZ2PHEYItZdWEYaqUIhIX6fsn0nXcplBKtVMxKZUkpKjePUz0L8p9T4tALgKTYs7JOm38vO9uCehHjZHejY9exkeX8dH78dG735In1nv6sya6mHIRh8Gm_7Gfcf0Fm8nZNQ |
CitedBy_id | crossref_primary_10_18632_aging_202638 crossref_primary_10_3724_abbs_2022194 crossref_primary_10_1002_kjm2_12522 crossref_primary_10_1007_s13258_021_01185_x crossref_primary_10_1615_CritRevEukaryotGeneExpr_2023048337 crossref_primary_10_1080_15476286_2021_1930755 crossref_primary_10_3389_fonc_2021_745166 crossref_primary_10_3390_genes15091139 crossref_primary_10_2147_CMAR_S287676 crossref_primary_10_3389_fonc_2021_765216 crossref_primary_10_1096_fj_202302475RRR crossref_primary_10_1186_s12935_020_01381_x crossref_primary_10_3389_fphar_2023_1091378 crossref_primary_10_1080_21655979_2021_1933868 crossref_primary_10_1155_2023_6785005 crossref_primary_10_1007_s10528_024_10750_4 crossref_primary_10_1097_MD_0000000000037322 crossref_primary_10_1038_s41598_021_90755_w crossref_primary_10_3390_ijms22126295 crossref_primary_10_1038_s41598_022_13045_z crossref_primary_10_1371_journal_pone_0252452 crossref_primary_10_1155_2021_6226291 crossref_primary_10_1016_j_heliyon_2024_e37715 crossref_primary_10_3389_pore_2021_587130 |
Cites_doi | 10.3390/ijms20123079 10.1158/0008-5472.CAN-19-1116 10.18632/aging.101933 10.18632/aging.102140 10.3934/mbe.2019347 10.1097/MPA.0000000000001230 10.1016/j.sigpro.2016.03.001 10.1002/jcp.28687 10.1016/j.phrs.2019.104511 10.3322/caac.21551 10.1016/j.bpg.2007.10.007 10.1158/1078-0432.CCR-14-0365 10.1159/000447872 10.3390/cancers11111628 10.1056/NEJM199305203282001 10.1016/j.biopha.2020.109972 10.1053/gast.1997.v113.pm9247480 10.1111/jcmm.14762 10.1200/JCO.2006.08.2644 10.1016/j.cell.2011.07.014 10.1002/1878-0261.12426 10.1007/s10555-015-9551-7 10.1038/75556 10.1158/0008-5472.CAN-19-0039 10.2147/OTT.S207748 10.1038/s41467-019-11019-w 10.1016/j.carj.2019.07.001 10.1158/1078-0432.CCR-18-3310 10.1093/nar/gkp896 10.1038/nature16965 10.1111/jcmm.14846 10.1056/NEJMcp054958 10.15252/embr.201948170 10.1002/1878-0261.12181 |
ContentType | Journal Article |
Copyright | The Author(s) 2020 The Author(s) 2020. 2020. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
Copyright_xml | – notice: The Author(s) 2020 – notice: The Author(s) 2020. – notice: 2020. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
DBID | C6C AAYXX CITATION NPM 3V. 7TM 7TO 7X7 7XB 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH H94 K9. M0S PHGZM PHGZT PIMPY PKEHL PQEST PQQKQ PQUKI PRINS 7X8 5PM DOA |
DOI | 10.1186/s12935-020-01243-6 |
DatabaseName | Springer Nature OA Free Journals CrossRef PubMed ProQuest Central (Corporate) Nucleic Acids Abstracts Oncogenes and Growth Factors Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest Central ProQuest One ProQuest Central Proquest Health Research Premium Collection Health Research Premium Collection (Alumni) AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Health & Medical Collection (Alumni) ProQuest Central Premium ProQuest One Academic (New) ProQuest Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
DatabaseTitle | CrossRef PubMed Publicly Available Content Database Oncogenes and Growth Factors Abstracts ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest One Academic Eastern Edition Nucleic Acids Abstracts ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Central China ProQuest Hospital Collection (Alumni) ProQuest Central ProQuest Health & Medical Complete Health Research Premium Collection ProQuest One Academic UKI Edition Health and Medicine Complete (Alumni Edition) ProQuest Central Korea AIDS and Cancer Research Abstracts ProQuest Central (New) ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | Publicly Available Content Database PubMed MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: C6C name: Springer Nature OA Free Journals url: http://www.springeropen.com/ sourceTypes: Publisher – sequence: 2 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 3 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 4 dbid: BENPR name: ProQuest Central url: http://www.proquest.com/pqcentral?accountid=15518 sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Biology |
EISSN | 1475-2867 |
EndPage | 14 |
ExternalDocumentID | oai_doaj_org_article_f0d3a99ed8334aa6b7e44a9ef40c22b6 PMC7288603 32536819 10_1186_s12935_020_01243_6 |
Genre | Journal Article Review |
GrantInformation_xml | – fundername: Provinces and Ministries Co-Contribution of Zhejiang, China grantid: WKJ-ZJ-2035 – fundername: the Natural Science Foundation of Zhejiang Province grantid: LY17H160057 – fundername: Key projects of Wenzhou science and technology bureau grantid: ZY2019016 – fundername: National Natural Sciences Foundation of China grantid: 81800567 – fundername: ; grantid: WKJ-ZJ-2035 – fundername: ; grantid: ZY2019016 – fundername: ; grantid: 81800567 – fundername: ; grantid: LY17H160057 |
GroupedDBID | --- 0R~ 29B 2WC 53G 5GY 5VS 6J9 7X7 8FI 8FJ AAFWJ AAJSJ AASML ABDBF ABUWG ACGFO ACGFS ACIHN ACIWK ACMJI ACPRK ACUHS ADBBV ADRAZ ADUKV AEAQA AENEX AFKRA AFPKN AFRAH AHBYD AHMBA AHYZX ALMA_UNASSIGNED_HOLDINGS AMKLP AMTXH AOIJS BAPOH BAWUL BCNDV BENPR BFQNJ BMC BPHCQ BVXVI C6C CCPQU CS3 DIK DU5 E3Z EBD EBLON EBS ESX F5P FYUFA GROUPED_DOAJ GX1 HMCUK HYE IAO IHR ISR ITC KQ8 M48 M~E O5R O5S OK1 OVT P2P PGMZT PHGZM PHGZT PIMPY PQQKQ PROAC PUEGO RBZ RNS ROL RPM RSV SBL SOJ TR2 TUS UKHRP W2D WOQ WOW XSB ~8M AAYXX CITATION 2VQ 4.4 88E 8R4 8R5 AHSBF ALIPV C1A EJD H13 IPNFZ LGEZI LOTEE M1P NADUK NPM NXXTH PJZUB PPXIY PSQYO RIG 3V. 7TM 7TO 7XB 8FK AZQEC DWQXO H94 K9. PKEHL PQEST PQUKI PRINS 7X8 5PM |
ID | FETCH-LOGICAL-c641t-b3af377677304578389fe468ffe41c96d9afcbc877e8db0571fa22c8ad3737553 |
IEDL.DBID | 7X7 |
ISSN | 1475-2867 |
IngestDate | Wed Aug 27 01:25:38 EDT 2025 Tue Sep 30 15:41:39 EDT 2025 Fri Sep 05 14:18:10 EDT 2025 Mon Jun 30 05:28:56 EDT 2025 Mon Jul 21 05:15:49 EDT 2025 Wed Oct 01 03:21:12 EDT 2025 Thu Apr 24 22:53:10 EDT 2025 Sat Sep 06 07:29:35 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | Pancreatic adenocarcinoma Competing endogenous RNA network Time-dependent receiver operating characteristic |
Language | English |
License | The Author(s) 2020. Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c641t-b3af377677304578389fe468ffe41c96d9afcbc877e8db0571fa22c8ad3737553 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 ObjectType-Review-3 content type line 23 |
ORCID | 0000-0002-5070-3834 |
OpenAccessLink | https://www.proquest.com/docview/2414889822?pq-origsite=%requestingapplication% |
PMID | 32536819 |
PQID | 2414889822 |
PQPubID | 42567 |
PageCount | 14 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_f0d3a99ed8334aa6b7e44a9ef40c22b6 pubmedcentral_primary_oai_pubmedcentral_nih_gov_7288603 proquest_miscellaneous_2413999281 proquest_journals_2414889822 pubmed_primary_32536819 crossref_citationtrail_10_1186_s12935_020_01243_6 crossref_primary_10_1186_s12935_020_01243_6 springer_journals_10_1186_s12935_020_01243_6 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2020-06-11 |
PublicationDateYYYYMMDD | 2020-06-11 |
PublicationDate_xml | – month: 06 year: 2020 text: 2020-06-11 day: 11 |
PublicationDecade | 2020 |
PublicationPlace | London |
PublicationPlace_xml | – name: London – name: England |
PublicationTitle | Cancer cell international |
PublicationTitleAbbrev | Cancer Cell Int |
PublicationTitleAlternate | Cancer Cell Int |
PublicationYear | 2020 |
Publisher | BioMed Central BMC |
Publisher_xml | – name: BioMed Central – name: BMC |
References | M Kanehisa (1243_CR18) 2010; 38 J Duan (1243_CR19) 2016; 127 G Luo (1243_CR21) 2019; 48 SC Credendino (1243_CR23) 2019 DC Whitcomb (1243_CR2) 2006; 354 C Li (1243_CR28) 2019; 11 B Staal (1243_CR9) 2019; 25 J Tang (1243_CR22) 2019; 20 BW Spanier (1243_CR3) 2008; 22 T Deng (1243_CR8) 2016; 39 S Greco (1243_CR14) 2019; 20 J Yang (1243_CR15) 2019 LB Wang (1243_CR29) 2019; 16 D Tang (1243_CR31) 2019; 234 GY Locker (1243_CR7) 2006; 24 H Ding (1243_CR30) 2019; 12 A Mcguire (1243_CR11) 2015; 34 PC Moore (1243_CR32) 2019; 79 L Salmena (1243_CR12) 2011; 146 B He (1243_CR13) 2017; 7 VO Oria (1243_CR26) 2019; 13 SK Natarajan (1243_CR35) 2019; 11 P Bailey (1243_CR25) 2016; 531 AF Abdel-Wahab (1243_CR34) 2019; 150 BF Zhang (1243_CR16) 2019; 24 BM Karlson (1243_CR5) 1997; 113 DP O’brien (1243_CR6) 2015; 21 W Wang (1243_CR24) 2019; 11 MT Taffel (1243_CR20) 2019; 70 Y Zhang (1243_CR10) 2018; 12 GC Shin (1243_CR33) 2019; 10 RL Siegel (1243_CR1) 2019; 69 M Ashburner (1243_CR17) 2000; 25 F Zhu (1243_CR27) 2020; 125 AB Lowenfels (1243_CR4) 1993; 328 32624707 - Cancer Cell Int. 2020 Jul 1;20:282 |
References_xml | – volume: 20 start-page: 3079 issue: 12 year: 2019 ident: 1243_CR14 publication-title: Int J Mol Sci doi: 10.3390/ijms20123079 – volume: 79 start-page: 6190 issue: 24 year: 2019 ident: 1243_CR32 publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-19-1116 – volume: 11 start-page: 2610 issue: 9 year: 2019 ident: 1243_CR24 publication-title: Aging doi: 10.18632/aging.101933 – volume: 11 start-page: 5593 issue: 15 year: 2019 ident: 1243_CR28 publication-title: Aging doi: 10.18632/aging.102140 – volume: 16 start-page: 6923 issue: 6 year: 2019 ident: 1243_CR29 publication-title: Math Biosci Eng doi: 10.3934/mbe.2019347 – volume: 48 start-page: 199 issue: 2 year: 2019 ident: 1243_CR21 publication-title: Pancreas doi: 10.1097/MPA.0000000000001230 – volume: 127 start-page: 239 year: 2016 ident: 1243_CR19 publication-title: Signal Process doi: 10.1016/j.sigpro.2016.03.001 – volume: 234 start-page: 20816 issue: 11 year: 2019 ident: 1243_CR31 publication-title: J Cell Physiol doi: 10.1002/jcp.28687 – volume: 150 start-page: 104511 year: 2019 ident: 1243_CR34 publication-title: Pharmacol Res doi: 10.1016/j.phrs.2019.104511 – volume: 69 start-page: 7 issue: 1 year: 2019 ident: 1243_CR1 publication-title: CA Cancer J Clin doi: 10.3322/caac.21551 – volume: 7 start-page: 1704 issue: 8 year: 2017 ident: 1243_CR13 publication-title: Am J Cancer Res – volume: 22 start-page: 45 issue: 1 year: 2008 ident: 1243_CR3 publication-title: Best Pract Res Clin Gastroenterol doi: 10.1016/j.bpg.2007.10.007 – volume: 21 start-page: 622 issue: 3 year: 2015 ident: 1243_CR6 publication-title: Clin Cancer Res doi: 10.1158/1078-0432.CCR-14-0365 – volume: 39 start-page: 1716 issue: 5 year: 2016 ident: 1243_CR8 publication-title: Cell Physiol Biochem doi: 10.1159/000447872 – volume: 11 start-page: 1628 issue: 11 year: 2019 ident: 1243_CR35 publication-title: Cancers doi: 10.3390/cancers11111628 – volume: 328 start-page: 1433 issue: 20 year: 1993 ident: 1243_CR4 publication-title: N Engl J Med doi: 10.1056/NEJM199305203282001 – volume: 125 start-page: 109972 year: 2020 ident: 1243_CR27 publication-title: Biomed Pharmacother doi: 10.1016/j.biopha.2020.109972 – volume: 113 start-page: 587 issue: 2 year: 1997 ident: 1243_CR5 publication-title: Gastroenterology doi: 10.1053/gast.1997.v113.pm9247480 – year: 2019 ident: 1243_CR15 publication-title: J Cell Mol Med. doi: 10.1111/jcmm.14762 – volume: 24 start-page: 5313 issue: 33 year: 2006 ident: 1243_CR7 publication-title: J Clin Oncol doi: 10.1200/JCO.2006.08.2644 – volume: 146 start-page: 353 issue: 3 year: 2011 ident: 1243_CR12 publication-title: Cell doi: 10.1016/j.cell.2011.07.014 – volume: 13 start-page: 456 issue: 2 year: 2019 ident: 1243_CR26 publication-title: Mol Oncol doi: 10.1002/1878-0261.12426 – volume: 34 start-page: 145 issue: 1 year: 2015 ident: 1243_CR11 publication-title: Cancer Metastasis Rev doi: 10.1007/s10555-015-9551-7 – volume: 25 start-page: 25 issue: 1 year: 2000 ident: 1243_CR17 publication-title: Nat Genet doi: 10.1038/75556 – year: 2019 ident: 1243_CR23 publication-title: Cancer Res. doi: 10.1158/0008-5472.CAN-19-0039 – volume: 12 start-page: 6733 year: 2019 ident: 1243_CR30 publication-title: Onco Targets Ther doi: 10.2147/OTT.S207748 – volume: 10 start-page: 3185 issue: 1 year: 2019 ident: 1243_CR33 publication-title: Nat Commun doi: 10.1038/s41467-019-11019-w – volume: 70 start-page: 416 issue: 4 year: 2019 ident: 1243_CR20 publication-title: Can Assoc Radiol J doi: 10.1016/j.carj.2019.07.001 – volume: 25 start-page: 2745 issue: 9 year: 2019 ident: 1243_CR9 publication-title: Clin Cancer Res doi: 10.1158/1078-0432.CCR-18-3310 – volume: 38 start-page: D355 issue: Database issue year: 2010 ident: 1243_CR18 publication-title: Nucleic Acids Res doi: 10.1093/nar/gkp896 – volume: 531 start-page: 47 issue: 7592 year: 2016 ident: 1243_CR25 publication-title: Nature doi: 10.1038/nature16965 – volume: 24 start-page: 1099 issue: 1 year: 2019 ident: 1243_CR16 publication-title: J Cell Mol Med. doi: 10.1111/jcmm.14846 – volume: 354 start-page: 2142 issue: 20 year: 2006 ident: 1243_CR2 publication-title: N Engl J Med doi: 10.1056/NEJMcp054958 – volume: 20 start-page: e48170 issue: 12 year: 2019 ident: 1243_CR22 publication-title: EMBO Rep. doi: 10.15252/embr.201948170 – volume: 12 start-page: 1429 issue: 9 year: 2018 ident: 1243_CR10 publication-title: Mol Oncol doi: 10.1002/1878-0261.12181 – reference: 32624707 - Cancer Cell Int. 2020 Jul 1;20:282 |
SSID | ssj0017860 |
Score | 2.3948743 |
SecondaryResourceType | review_article |
Snippet | Background
Emerging evidence suggests that competing endogenous RNAs plays a crucial role in the development and progress of pancreatic adenocarcinoma (PAAD).... Emerging evidence suggests that competing endogenous RNAs plays a crucial role in the development and progress of pancreatic adenocarcinoma (PAAD). The... Background Emerging evidence suggests that competing endogenous RNAs plays a crucial role in the development and progress of pancreatic adenocarcinoma (PAAD).... Abstract Background Emerging evidence suggests that competing endogenous RNAs plays a crucial role in the development and progress of pancreatic adenocarcinoma... |
SourceID | doaj pubmedcentral proquest pubmed crossref springer |
SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 231 |
SubjectTerms | Accuracy Adenocarcinoma Biomedical and Life Sciences Biomedicine Cancer Research Cell Biology Competing endogenous RNA network Gene expression Genes Genomes Genotypes Homeostasis Hypotheses Medical prognosis Metabolism MicroRNAs miRNA mRNA Non-coding RNA Pancreas Pancreatic adenocarcinoma Pancreatic cancer Prognosis Time-dependent receiver operating characteristic |
SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1LaxUxFD5IoeBGfDtaSwR3OnTyzixraSmCXYiF7kImD7yoM9J7XfjvPUlmrl6fGzezmDwI55zkfEnO-QLwPPkgORtoi2A1tCLn5QyGxtZ75gMXPkSVc4ffXKjzS_H6Sl798NRXjgmr9MBVcEepC9z1fQyGc-GcGnQUwvUxic4zNhSybXRjy2Zqvj_QRnVLioxRR-vs1XImcg7CYoK3ascNFbb-30HMXyMlf7ouLV7o7DbcmuEjOa7DvgM34ngX9uuDkl_vwYead5vmgzgyJeKIL9AYuyNxDFMlZSVvL47JWEPAiZtVFAPJx7Ikx2yN03q1zu1xtajA0hOHnaPru_arcfrk7sPl2em7k_N2fk6h9UrQTTtwl3gm79H5dlQbhCopCmUSfqnvVehd8oM3WkcTBsRxNDnGvHGBa66l5A9gb5zG-AhI5zyPQZpe9p2IkTkenWTBe0k1rhmiAbpI1_qZazw_efHRlj2HUbZqxKJGbNGIVQ282Lb5XJk2_lr7VVbatmZmyS4_0HbsbDv2X7bTwMGicjtP3bVFSIOLWqY1bODZthgnXb5JcWNEHeU6COx6ZmgDD6uFbEfCmeQKcVYDesd2doa6WzKu3hdib80M2i1v4OViZd-H9WdRPP4fongCN1mZHqql9AD2Ntdf4lOEW5vhsMysb8PHKDQ priority: 102 providerName: Directory of Open Access Journals – databaseName: Scholars Portal Journals: Open Access dbid: M48 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwELZKERIXxJtAQUZCXCAQP2I7B4QKoqqQ2gNipd4sxw9YUZJ2d5Hov2fGSbZaWHrZw8axHM83ni-ZFyEvkg-14C0rgayGUmJeTmtYLL3nPgjpQ1SYO3x0rA5n8vNJfbJDpnDbcQOXW1_tsJ_UbHH65vf5xXtQ-HdZ4Y16u0SbhXnGGGLFpSjVy7PzEhtLoQN27LJxjVwHY8UR-Efy0tGgjaqmXJqtU23Yq1zWfxsX_Tek8i-_ajZXB7fJrZFn0v0BGHfITuzukhtD58mLe-THkKCbxi92tE_UUZ85NExHYxf6oXor_XK8T7shVpy6UZYxUPx-SzG4q-uX8yXeD8fKwEA9dTA52MiFn3f9T3efzA4-ff14WI59F0qvJFuVrXBJYJUfjW5UbYDTpCiVSfDLfKNC45JvvdE6mtAC4WPJce6NC0ILXdfiAdnt-i4-IrRyXsRQm6ZuKhkjdyK6mgfva6bhcJEFYdPuWj8WJcfeGKc2v5wYZQeJWJCIzRKxqiCv1vecDSU5rhz9AYW2HonltPMf_eKbHbXTpioI1zQxGCGkc6rVUUrXxCQrz3kLk-xNIrcTRC3ACU4_rH9YkOfry6Cd6HJxXQQZ4RhggA03rCAPB4SsVyJ4LRQQsoLoDexsLHXzSjf_niuAa24At6IgryeUXS7r_1vx-OqneEJu8gx8VTK2R3ZXi1_xKTCuVfss68wf6RApkw priority: 102 providerName: Scholars Portal – databaseName: Springer Nature OA Free Journals dbid: C6C link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3Ni9UwEA-6IngRv62uEsGbFpvv9Lg-XBbBPYgLewtpPvChprLvefC_d6bpqz5dBS89tJMQMjPJr5mZXwh5nkNUgg-sBbAaW4l1OYNlqQ2BhyhkiElj7fC7U31yJt-eq_OZJgdrYX6N3zOrX21wP8IaYkyf4lK0-iq5pmDhxfS9lV4tEQNjdbcrirm03d7GM_HzXwYq_8yN_C1AOu07x7fIzRkw0qOq4dvkSip3yPV6heT3u-RTrbTN89EbHTP1NExgGLqjqcSx0rDS96dHtNSkb-pnpaRI8SCWYpZWGTfrDbaH9aFCyUA9dA6b3UVYl_GLv0fOjt98WJ208wUKbdCSbdtB-CyQrsdgPNRYACc5SW0zPFnodex9DkOwxiQbB0BuLHvOg_VRGGGUEvfJQRlLekho54NIUdle9Z1MiXuRvOIxBMUMrBKyIWw3uy7M7OJ4ycVnN_1lWO2qRhxoxE0acbohL5Y2Xyu3xj-lX6PSFknkxZ5egLm42c1c7qLwfZ-iFUJ6rweTpPR9yrILnA_QyeFO5W521o0DEAPLGBIZNuTZ8hncDGMnviTQEcoAlOu5ZQ15UC1kGYngSmhAVg0xe7azN9T9L2X9caLyNtyC3YqGvNxZ2c9h_X0qHv2f-GNyg0-OoFvGDsnB9uJbegJQajs8nXzoB-0UF6U priority: 102 providerName: Springer Nature |
Title | Identification of a competing endogenous RNA network associated with prognosis of pancreatic adenocarcinoma |
URI | https://link.springer.com/article/10.1186/s12935-020-01243-6 https://www.ncbi.nlm.nih.gov/pubmed/32536819 https://www.proquest.com/docview/2414889822 https://www.proquest.com/docview/2413999281 https://pubmed.ncbi.nlm.nih.gov/PMC7288603 https://doaj.org/article/f0d3a99ed8334aa6b7e44a9ef40c22b6 |
Volume | 20 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
journalDatabaseRights | – providerCode: PRVADU databaseName: BioMed Central Open Access Free customDbUrl: eissn: 1475-2867 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0017860 issn: 1475-2867 databaseCode: RBZ dateStart: 20010101 isFulltext: true titleUrlDefault: https://www.biomedcentral.com/search/ providerName: BioMedCentral – providerCode: PRVAFT databaseName: Colorado Digital library customDbUrl: eissn: 1475-2867 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0017860 issn: 1475-2867 databaseCode: KQ8 dateStart: 20011101 isFulltext: true titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html providerName: Colorado Alliance of Research Libraries – providerCode: PRVAFT databaseName: Colorado Digital library customDbUrl: eissn: 1475-2867 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0017860 issn: 1475-2867 databaseCode: KQ8 dateStart: 20010101 isFulltext: true titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html providerName: Colorado Alliance of Research Libraries – providerCode: PRVAON databaseName: DOAJ Directory of Open Access Journals customDbUrl: eissn: 1475-2867 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0017860 issn: 1475-2867 databaseCode: DOA dateStart: 20010101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals – providerCode: PRVEBS databaseName: EBSCOhost Academic Search Ultimate customDbUrl: https://search.ebscohost.com/login.aspx?authtype=ip,shib&custid=s3936755&profile=ehost&defaultdb=asn eissn: 1475-2867 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0017860 issn: 1475-2867 databaseCode: ABDBF dateStart: 20010101 isFulltext: true titleUrlDefault: https://search.ebscohost.com/direct.asp?db=asn providerName: EBSCOhost – providerCode: PRVBFR databaseName: Free Medical Journals customDbUrl: eissn: 1475-2867 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0017860 issn: 1475-2867 databaseCode: DIK dateStart: 20010101 isFulltext: true titleUrlDefault: http://www.freemedicaljournals.com providerName: Flying Publisher – providerCode: PRVFQY databaseName: GFMER Free Medical Journals customDbUrl: eissn: 1475-2867 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0017860 issn: 1475-2867 databaseCode: GX1 dateStart: 20010101 isFulltext: true titleUrlDefault: http://www.gfmer.ch/Medical_journals/Free_medical.php providerName: Geneva Foundation for Medical Education and Research – providerCode: PRVHPJ databaseName: ROAD: Directory of Open Access Scholarly Resources customDbUrl: eissn: 1475-2867 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0017860 issn: 1475-2867 databaseCode: M~E dateStart: 20010101 isFulltext: true titleUrlDefault: https://road.issn.org providerName: ISSN International Centre – providerCode: PRVAQN databaseName: PubMed Central (Free e-resource, activated by CARLI) customDbUrl: eissn: 1475-2867 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0017860 issn: 1475-2867 databaseCode: RPM dateStart: 20010101 isFulltext: true titleUrlDefault: https://www.ncbi.nlm.nih.gov/pmc/ providerName: National Library of Medicine – providerCode: PRVPQU databaseName: Health & Medical Collection customDbUrl: eissn: 1475-2867 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0017860 issn: 1475-2867 databaseCode: 7X7 dateStart: 20090101 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Central customDbUrl: http://www.proquest.com/pqcentral?accountid=15518 eissn: 1475-2867 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0017860 issn: 1475-2867 databaseCode: BENPR dateStart: 20090101 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest – providerCode: PRVFZP databaseName: Scholars Portal Journals: Open Access customDbUrl: eissn: 1475-2867 dateEnd: 20250131 omitProxy: true ssIdentifier: ssj0017860 issn: 1475-2867 databaseCode: M48 dateStart: 20011101 isFulltext: true titleUrlDefault: http://journals.scholarsportal.info providerName: Scholars Portal – providerCode: PRVAVX databaseName: Springer Nature HAS Fully OA customDbUrl: eissn: 1475-2867 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0017860 issn: 1475-2867 databaseCode: AAJSJ dateStart: 20011201 isFulltext: true titleUrlDefault: https://www.springernature.com providerName: Springer Nature – providerCode: PRVAVX databaseName: Springer Nature OA Free Journals customDbUrl: eissn: 1475-2867 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0017860 issn: 1475-2867 databaseCode: C6C dateStart: 20011201 isFulltext: true titleUrlDefault: http://www.springeropen.com/ providerName: Springer Nature |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1bi9QwFA66i-CLeLe6DhF807LNpUn6JDvDLouwgwwuDL6ENEl1UNt1Oj747z1J0y7jZV8CbdKQ5pzkfDk5F4ReN9aVjNYkB7Dqch78cmpFfG4ttY5x67wIvsMXS3F-yd-vy3VSuPXJrHLcE-NG7TobdOTHIGmA10K0uXdXP_KQNSrcrqYUGrfRIQGoErharqcDF5FKFKOjjBLHfZBtwR85mGJRznKxJ4xizP5_Ac2_7SX_uDSNsujsPrqXQCQ-Gaj-AN3y7UN0Z0gr-esR-jp43zZJHYe7BhtsI0CG7rBvXTeEZsWr5QluB0NwbBKhvMNBOYuD5Vbb9Zs-fA97xgAvLTbQOQjArd203XfzGF2enX5cnOcpqUJuBSe7vGamYSGEjwx3pFIBYGk8F6qBkthKuMo0trZKSq9cDWiONIZSq4xjksmyZE_QQdu1_hnChbHMu1JVZVVw76lh3pTUWVsSCTsHzxAZZ1fbFHE8JL74puPJQwk9UEQDRXSkiBYZejN9czXE27ix9TwQbWoZYmXHF932s05LTzeFY6aqvFOMcWNELT3npvINLyylNXRyNJJcpwXc62t2y9CrqRqWXrhPMa0HGoU2AO8qqkiGng4cMo2E0ZIJQFsZknu8szfU_Zp28yWG95ZUAd-yDL0duex6WP-fiuc3_8ULdJdGxhc5IUfoYLf96V8CnNrVs7hmZuhwfrr8sIKnhVjMomoCyguuoFzNP_0Ghw0kQA |
linkProvider | ProQuest |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Jb9QwFLaqIgQXxE6ggJHgBFHjJbZzQKgs1ZS2c0CtNDfj2A6MgKRMBqH-KX4j72WZalh66yWHxLYcv-8ttt9CyNPKh1zwkqVgrIZUYlxOaVhMvec-COlDVBg7fDhVk2P5fpbPNsivMRYG3SpHmdgJ6tB4PCPfBk0DWMNsc69OvqdYNQpvV8cSGj0s9uPpT9iytS_33gJ9n3G---7ozSQdqgqkXkm2TEvhKoE5bDReEmoDGruKUpkKnswXKhSu8qU3WkcTSjBnWOU498YFoYXOsUoEiPxLEnpjrn49W23wmDYqGwNzjNpuUZdi_DO6fnEpUrWm_LoaAf8ybP_2z_zjkrbTfbvXybXBaKU7PcpukI1Y3ySX-zKWp7fIlz7atxqO_2hTUUd9Z5DDcDTWoelTwdIP0x1a947n1A3AiIHiYTBFT7G6aect9gcZ1ZuznjoYHBTuws_r5pu7TY4vZLnvkM26qeM9QjPnRQy5KfIikzFyJ6LLefA-ZxoklUwIG1fX-iHDORba-Gq7nY5RtqeIBYrYjiJWJeT5qs9Jn9_j3NavkWirlpibu3vRLD7ZgdVtlQXhiiIGI4R0TpU6SumKWMnMc17CIFsjye0gMFp7Bu-EPFl9BlbH-xtXR6ARtgFzsuCGJeRuj5DVTATPhQLrLiF6DTtrU13_Us8_d-nENTeAW5GQFyPKzqb1_6W4f_5fPCZXJkeHB_Zgb7r_gFzlHROolLEtsrlc_IgPwZRblo86_qHk40Uz7G_BlVuB |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1LjxQhECa6G40X49vWVTHxpp1tHg30cXxM1lEnRt1kb4TmoROV3syMB_-9RdPdOrqaeOlDUxBCUfBBVX0g9ChYVzPakhLAqit5ystpFfGltdQ6xq3zIuUOv1mKo2O-OKlPfsni76PdR5dkzmlILE1xe3jqQjZxJQ43aZdKmcUpqIpyVorzaF_VjYDj1_5stni_mDwJUolqTJY5s-bOhtTz9p8FNv-MmfzNcdrvR_Mr6PIAJPEsa_4qOufjNXQhPy35_Tr6nDNww3Alh7uADbY9SIbmsI-uy_Ss-N1yhmMOBsdmUJZ3OF3Q4hS9FbvNapPqw7qRIabFBhqHTXBtV7H7am6g4_mLD8-OyuFhhdIKTrZly0xgicZHJj-pVABagudCBfgS2wjXmGBbq6T0yrWA6EgwlFplHJNM1jW7ifZiF_1thCtjmXe1auqm4t5Tw7ypqbO2JhJWD14gMo6utgPreHr84ovuTx9K6KwRDRrRvUa0KNDjqc5p5tz4p_TTpLRJMvFl9z-69Uc9mJ8OlWOmabxTjHFjRCs956bxgVeW0hYaORhVrgcj3mgAN7C8JYLDAj2cisH8kk_FRA86SjIA8RqqSIFu5Rky9YTRmglAXAWSO3Nnp6u7JXH1qaf4llTBvGUFejLOsp_d-vtQ3Pk_8Qfo4tvnc_365fLVXXSJ9jYhSkIO0N52_c3fA7S1be8PBvUDNUUkUA |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Identification+of+a+competing+endogenous+RNA+network+associated+with+prognosis+of+pancreatic+adenocarcinoma&rft.jtitle=Cancer+cell+international&rft.au=Weng%2C+Wanqing&rft.au=Zhang%2C+Zhongjing&rft.au=Huang%2C+Weiguo&rft.au=Xu%2C+Xiangxiang&rft.date=2020-06-11&rft.pub=BioMed+Central&rft.eissn=1475-2867&rft.volume=20&rft.spage=1&rft_id=info:doi/10.1186%2Fs12935-020-01243-6 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1475-2867&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1475-2867&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1475-2867&client=summon |